Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.
- 29 August 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 92 (18), 8264-8268
- https://doi.org/10.1073/pnas.92.18.8264
Abstract
To develop a murine model system to test the role of monocyte-derived macrophage in atherosclerosis, the osteopetrotic (op) mutation in the macrophage colony-stimulating factor gene was bred onto the apolipoprotein E (apoE)-deficient background. The doubly mutant (op/apoE-deficient) mice fed a low-fat chow diet had significantly smaller proximal aortic lesions at an earlier stage of progression than their apoE-deficient control littermates. These lesions in the doubly mutant mice were composed of macrophage foam cells. The op/apoE-deficient mice also had decreased body weights, decreased blood monocyte differentials, and increased mean cholesterol levels of approximately 1300 mg/dl. Statistical analysis determined that atherosclerosis lesion area was significantly affected by the op genotype and gender. The confounding variables of body weight, plasma cholesterol, and monocyte differential, which were all affected by op genotype, had no significant additional effect on lesion area once they were adjusted for the effects of op genotype and gender. Unexpectedly, there was a significant inverse correlation between plasma cholesterol and lesion area, implying that each may be the result of a common effect of macrophage colony-stimulating factor levels. The data support the hypothesis that macrophage colony-stimulating factor and its effects on macrophage development and function play a key role in atherogenesis.Keywords
This publication has 32 references indexed in Scilit:
- Colony stimulating factor 1 is required for mammary gland development during pregnancy.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouseDevelopment, 1994
- Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.1991
- Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1991
- Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages.Journal of Biological Chemistry, 1990
- Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.Proceedings of the National Academy of Sciences of the United States of America, 1990
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor geneNature, 1990
- SERUM CHOLESTEROL-LOWERING ACTIVITY OF HUMAN MONOCYTIC COLONY-STIMULATING FACTORThe Lancet, 1989
- Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.Journal of Biological Chemistry, 1982